| Name | Title | Contact Details |
|---|
With more than 51 programs across the U.S. and abroad, RI specializes in Crisis, Health, Recovery and Consulting Services. RI Crisis is rapidly expanding while enhancing technologies and service lines within our existing array of RRC`s(Crisis Stabilization Programs), E&Ts (Involuntary & Court-ordered Treatment), and Crisis Respites.
CrescentCare is an organization of health and wellness centers that is responding to the need for broader healthcare services in the Greater New Orleans area. CrescentCare uses proven interventions and evidence-based practices to improve outcomes for i...
Patients vary in more ways than gender, race, and size. At Conformis, we believe that optimizing implant fit and performance requires a patient-specific approach. Our mission is to provide best-in-class, patient-specific implants and instrumentation that offer unique advantages over traditional orthopedic implants. We start with a simple idea: make the implant fit the patient rather than forcing the patient to fit the implant. Our implants are individually sized and shaped to fit to each patient`s unique anatomy, providing precise anatomic fit and preserving healthy tissue. Our disposable, patient-specific cutting and placement guides also eliminate many of the tools required for traditional orthopedic surgery and simplify surgical technique. By combining our personalized implants with our unique instrumentation, a surgeon is able to provide a custom solution that preserves more of a patient`s joint and minimizes surgical trauma. Conformis, Inc. is a privately held medical device company based in Massachusetts. It was founded in 2004 to provide dramatic advancements in patient care by utilizing imaging technology to create personalized, patient-specific implants and instrumentation.
AmeriChoice of New York is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nu-Med Plus, Inc. is a medical device development company created to explore medical applications of newly developed technologies. The strategy is to concentrate on high growth potential markets where there are visible, distinct needs recognized by the medical community that can be addressed by Nu-Med Plus and its technical expertise. Initial research and product development has been in the delivery of nitric oxide gas for therapeutic use.